{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:53:43Z","timestamp":1774079623847,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Myeloma Canada"},{"DOI":"10.13039\/100019211","name":"AbbVie Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Validated patient- and caregiver-reported outcome (PRO and CRO) questionnaires are widely used to assess quality of life (QoL) in multiple myeloma (MM). However, most were developed before recent therapeutic advances that have modified disease trajectories and may no longer fully reflect patients\u2019 and caregivers\u2019 experiences. Methods: A Canadian cross-sectional observational study was conducted in collaboration with the PROxy Network and Myeloma Canada. Patients with MM completed the EORTC QLQ-C30, EORTC QLQ-MY20, EQ-5D-5L, and ESAS-R questionnaires and caregivers of patients with MM completed the CarGOQoL. Both groups rated their perceived QoL using a numerical rating scale. The strength of associations between validated questionnaire global scores and self-perceived QoL was assessed using Spearman\u2019s correlation coefficient (r). Results: Between October 2024 and February 2025, the study enrolled 305 patients and 104 caregivers. Moderate correlations were observed between patients\u2019 perceived QoL and validated PRO global scores (range of r: 0.59 to 0.65). The MM-specific QLQ-MY20 showed one of the lowest correlations (r = 0.59; 95% confidence interval (CI) 0.51\u20130.66; p &lt; 0.001). The caregiver-reported CarGOQoL also demonstrated a moderate association (r = 0.54; 95% CI 0.38\u20130.67; p &lt; 0.001). Conclusions: Contemporary treatment advances, including prolonged survival and evolving side effect profiles, may not be reflected in currently available PRO and CRO instruments.<\/jats:p>","DOI":"10.3390\/curroncol33030174","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:38:01Z","timestamp":1773934681000},"page":"174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging Perspectives: How Canadian Patients and Caregivers View Quality of Life in Multiple Myeloma Compared to Validated Instruments"],"prefix":"10.3390","volume":"33","author":[{"given":"Julie","family":"Patenaude","sequence":"first","affiliation":[{"name":"PeriPharm Inc., 420 Notre-Dame Ouest, Suite 501, Montreal, QC H2Y 1V3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4923-1231","authenticated-orcid":false,"given":"Ariane","family":"L\u00e9gar\u00e9","sequence":"additional","affiliation":[{"name":"PeriPharm Inc., 420 Notre-Dame Ouest, Suite 501, Montreal, QC H2Y 1V3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Dupont","sequence":"additional","affiliation":[{"name":"PeriPharm Inc., 420 Notre-Dame Ouest, Suite 501, Montreal, QC H2Y 1V3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Colasurdo","sequence":"additional","affiliation":[{"name":"Myeloma Canada, 1255 TransCanada, Suite 160, Dorval, QC H9P 2V4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Elias","sequence":"additional","affiliation":[{"name":"Myeloma Canada, 1255 TransCanada, Suite 160, Dorval, QC H9P 2V4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-5430","authenticated-orcid":false,"given":"Catherine","family":"Beauchemin","sequence":"additional","affiliation":[{"name":"PeriPharm Inc., 420 Notre-Dame Ouest, Suite 501, Montreal, QC H2Y 1V3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0791-2518","authenticated-orcid":false,"given":"Jean","family":"Lachaine","sequence":"additional","affiliation":[{"name":"PeriPharm Inc., 420 Notre-Dame Ouest, Suite 501, Montreal, QC H2Y 1V3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"Pawlyn","year":"2021","journal-title":"Lancet"},{"key":"ref_2","unstructured":"Myeloma Canada (2025, May 10). Myeloma Canada, Making Myeloma Matter. Available online: https:\/\/myeloma.ca\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/cncr.32128","article-title":"Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study","volume":"125","author":"Tsang","year":"2019","journal-title":"Cancer"},{"key":"ref_4","unstructured":"Canadian Cancer Society (2025, December 16). GoC. Canadian Cancer Statistics 2025. Available online: http:\/\/cancer.ca\/Canadian-Cancer-Statistics-2025-EN."},{"key":"ref_5","unstructured":"Canadian Cancer Society (2023, September 18). What Is Multiple Myeloma?. Available online: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/multiple-myeloma\/what-is-multiple-myeloma."},{"key":"ref_6","unstructured":"Centers for Disease Control and Prevention (2025, May 10). Myeloma, Available online: https:\/\/www.cdc.gov\/myeloma\/about\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/cancer\/myeloma\/index.htm."},{"key":"ref_7","unstructured":"Canadian Cancer Society (2023, September 18). Symptoms of Multiple Myeloma. Available online: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/multiple-myeloma\/signs-and-symptoms."},{"key":"ref_8","unstructured":"Canadian Cancer Society (2023, September 18). Treatments for Multiple Myeloma. Available online: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/multiple-myeloma\/treatment."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clml.2022.01.009","article-title":"Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021","volume":"22","author":"Efficace","year":"2022","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","article-title":"Health related quality of life in a nationally representative sample of haematological patients","volume":"83","author":"Johnsen","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pon.1710","article-title":"Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners","volume":"20","author":"Molassiotis","year":"2011","journal-title":"Psycho-Oncology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1182\/bloodadvances.2022007127","article-title":"Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma","volume":"6","author":"Shapiro","year":"2022","journal-title":"Blood Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.12968\/bjon.2023.32.5.S10","article-title":"A survey of quality-of-life tools used in the routine care of patients with multiple myeloma","volume":"32","author":"Kirkpatrick","year":"2023","journal-title":"Br. J. Nurs."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.clml.2023.03.005","article-title":"Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review","volume":"23","author":"Fonseca","year":"2023","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.1182\/blood-2022-167272","article-title":"Survey of the Relevance of Quality of Life (QoL) Questionnaires (QoLQs) Currently Used to Evaluate Multiple Myeloma (MM) Patients\u2019 Qol in Real-World MM Patients and Healthcare Professionals (HCPs)","volume":"140","author":"Bristogiannis","year":"2022","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41408-021-00543-y","article-title":"Review of patient-reported outcomes in multiple myeloma registrational trials: Highlighting areas for improvement","volume":"11","author":"Fernandes","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_17","first-page":"431","article-title":"Assessment tools for patient-reported outcomes in multiple myeloma","volume":"31","author":"Wang","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_18","unstructured":"Fayers, P.M.A.N., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., and on behalf of the EORTC Quality of Life Group (2023, September 25). The EORTC QLQ-C30 Scoring Manual (3rd Edition). European Organisation for Research and Treatment of Cancer. Updated 2018. Available online: https:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf."},{"key":"ref_19","unstructured":"EORTC Quality of Life (2023, September 25). Multiple Myeloma (Update of MY20). Available online: https:\/\/qol.eortc.org\/questionnaire\/multiple-myeloma-update-of-my20\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study","volume":"22","author":"Janssen","year":"2013","journal-title":"Qual. Life Res."},{"key":"ref_21","unstructured":"Reenen, M.V. (2023, September 25). EQ-5D-5L User Guide\u2014Basic Information on How to Use the EQ-5D-5L Instrument. Available online: http:\/\/www.euroqol.org\/fileadmin\/user_upload\/Documenten\/PDF\/Folders_Flyers\/EQ-5D-5L_UserGuide_2015.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"A time trade-off-derived value set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med. Care"},{"key":"ref_23","unstructured":"Alberta Health Services (AHS) (2019). Edmonton Symptom Assessment System\u2014Revised (ESAS-r)\u2014Administration Manual, Alberta Health Services (AHS)."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","article-title":"The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments","volume":"53","author":"Hui","year":"2017","journal-title":"J. Pain Symptom Manag."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ejca.2011.09.010","article-title":"The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): Development and validation of an instrument to measure the quality of life of the caregivers of patients with cancer","volume":"48","author":"Minaya","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_26","unstructured":"(2025, May 10). Dcipher Analytics. Dcipher Studio. Available online: https:\/\/www.dcipheranalytics.com\/products\/dcipher-studio."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e39068","DOI":"10.2196\/39068","article-title":"Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review","volume":"8","author":"Lyall","year":"2022","journal-title":"JMIR Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.25259\/IJPC_175_2022","article-title":"Correlation between Quality of Life and Burden in Caregivers of Advanced Stage Cancer Patients on Best Supportive Care","volume":"29","author":"Manivannan","year":"2023","journal-title":"Indian J. Palliat. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.6004\/jnccn.2020.7561","article-title":"Symptom Burden, Perceived Control, and Quality of Life Among Patients Living With Multiple Myeloma","volume":"18","author":"Zaleta","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4172\/1948-5956.1000430","article-title":"Quality of Life in Patients with Multiple Myeloma: A Qualitative Study","volume":"8","author":"Mortensen","year":"2016","journal-title":"J. Cancer Sci. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7525-12-35","article-title":"Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma","volume":"12","author":"Proskorovsky","year":"2014","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_32","unstructured":"Statistics Canada (2022). Highest Level of Education by Census Year, Visible Minority and Generation Status: Canada, Provinces and Territories, Census Metropolitan Areas and Census Agglomerations, Statistics Canada. Table 98-10-0429-01."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/oxfordjournals.aje.a009937","article-title":"Bias and precision in visual analogue scales: A randomized controlled trial","volume":"150","author":"Guillemin","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/stan.12111","article-title":"Analytic posteriors for Pearson\u2019s correlation coefficient","volume":"72","author":"Ly","year":"2018","journal-title":"Stat. Neerl."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:35:35Z","timestamp":1774071335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["curroncol33030174"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33030174","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}